Jonathan M. Hagedorn

Department of Anesthesiology and Perioperative Medicine, Division of Pain Medicine, Mayo Clinic, Rochester, MN, USA

Publications
  • Mini Review   
    Discussion of Targeted Drug Delivery Article
    Author(s): David Schultz*, Jonathan M. Hagedorn, Scott Stayner and Caitlin Bakke

    Targeted Drug Delivery (TDD) is commonly used for the management of patients with intractable pain. Past studies have proven efficacy in pain relief and reduction in opioid use and cost-effectiveness in long-term pain management. There are few studies investigating satisfaction amongst patients with implanted pain pumps that are managed with targeted intrathecal medications. We published a study in Neuromodulation in April of 2020 describing patient satisfaction with TDD in single medical practice for patients implanted with pain pumps for relief of intractable chronic benign pain. Six hundred and ten active TDD patients were identified, and an anonymous 18-question survey was administered to determine satisfaction with TDD therapy. Four hundred and forty-three patients (74% of the active pump population) completed the survey. Most patients reported improvement i.. View more»

    DOI: 10.35248/2684-1320.21.7.152

    Abstract HTML PDF